Neurodevelopmental and psychiatric issues in down's syndrome: Assessment and intervention

Psychiatric Genetics

Volumn 23, Issue 3, 2013, Pages 95-107

  Vicari, Stefano ^a   Pontillo, Maria ^a   Armando, Marco ^a,b,c  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

assessment; Downs syndrome; intellectual disability; neurodevelopment; psychiatric disorders; treatment

Indexed keywords

ATOMOXETINE; ATYPICAL ANTIPSYCHOTIC AGENT; FOLIC ACID; GUANFACINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; PSYCHOSTIMULANT AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AGING; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR DISORDER; COGNITIVE DEFECT; DEPRESSION; DOWN SYNDROME; FOLATE METABOLISM; HUMAN; INTELLECTUAL IMPAIRMENT; LANGUAGE DISABILITY; NERVOUS SYSTEM DEVELOPMENT; OBSESSIVE COMPULSIVE DISORDER; OXIDATIVE STRESS; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SPEECH DISORDER; TRISOMY 21; UNSPECIFIED SIDE EFFECT; VITAMIN SUPPLEMENTATION;

COGNITION; DOWN SYNDROME; HUMANS; MEMORY; MENTAL DISORDERS;

EID: 84876876673     PISSN: 09558829     EISSN: 14735873     Source Type: Journal    
DOI: 10.1097/YPG.0b013e32835fe426     Document Type: Review

References (157)

1. Albert M, Cohen C (1992). The test for severe impairment: an instrument for the assessment of patients with severe cognitive dysfunction. J Am Geriatr Soc 40:449-453.
2. Alexander GE, Saunders AM, Szczepanik J, Strassburger TL, Pietrini P, Dani A, et al. (1997). Relation of age and apolipoprotein E to cognitive function in Down syndrome adults. NeuroReport 8:1835-1840.
3. Aman MG, Crismon ML, Frances A, King BH, Rojahn J (2004). Treatment of psychiatric and behavioral problems in individuals with mental retardation: an update of expert consensus guidelines. Englewood, CA: Postgraduate Institute of Medicine and Jobson Education.
4. Andreou G, Galanopoulou C, Gourgoulianis K (2002). Cognitive status in Down syndrome individuals with sleep disordered breathing deficits. Brain Cogn 50:145-149.
5. Armando M, Nelson B, Yung AR, Ross M, Birchwood M, Girardi P, et al. (2010). Psychotic-like experiences, self-disturbance and depressive symptoms in a community sample of adolescents and young adults. Schizophr Res 119:258-265.
6. Armando M, Papaleo F, Vicari S (2012). Chromosome 22q11 microdeletion syndrome, COMT functional polymorphism and cognitive/psychiatric correlates. CNS Neurolo Disord Drug Targets 11:273-281.
7. Aylward EH, Li Q, Habbak QR, Warren A, Pulsifer MB, Barta PE, et al. (1997). Basal ganglia volume in adults with Down syndrome. Psychiatry Res 74: 73-82.
8. Ball SL, Holland AJ, Huppert FA, Treppner P, Watson P, Hon J (2004). The modified CAMDEX informant interview is a valid and reliable tool for use in the diagnosis of dementia in adults with Down's syndrome. J Intellect Disabil Res 48:611-620.
9. Bennett FC, McClelland S, Kriegsmann EA, Andrus LB, Sells CJ (1983). Vitamin and mineral supplementation in Down's syndrome. Pediatrics 72:707-713.
10. Bhattacharyya R, Sanyal D, Roy K, Saha S (2009). A study of cluster behavioral abnormalities in Down syndrome. Indian J Med Sci 63:58-65.
11. Bhattacharyya R, Sanyal D, Roy K, Bhattacharyya S (2010). Correlation between physical anomaly and behavioral abnormalities in Down syndrome. J Pediatr Neuroscience 5:105-110.
12. Bidder RT, Gray P, Newcombe RG, Evans BK, Hughes M (1989). The effects of multivitamins and minerals on children with Down syndrome. Dev Med Child Neurol 31:532-537.
13. Brock J, Jarrold C (2004). Language influences on verbal short-term memory in Down syndrome: item and order recognition. J Speech Lang Hear Res 47:1334-1346.
14. Brooksbank BW, Balazs R (1984). Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Down's syndrome fetal brain. Brain Res 318:37-44.
15. Burt DB, Aylward EH (2000). Test battery for the diagnosis of dementia in individuals with intellectual disability. J Intellect Disabil Res 44:175-180.
16. Busciglio J, Yankner BA (1995). Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 378:776-779.
17. Bush A, Beail N (2004). Risk factors for dementia in people with Down syndrome: issues in assessment and diagnosis. Am J Ment Retard 109:83-97.
18. Capone G, Goyal P, Ares W, Lannigan E (2006). Neurobehavioral disorders in children, adolescents, and young adults with Down syndrome. Am J Med Genet C Semin Med Genet 142:158-172.
19. Capone GT, Grados MA, Kaufman WE, Bernad-Ripoll S, Jewell A (2005). Down syndrome and co-morbid autism spectrum disorder: characterization using the aberrant behavior checklist. Am J Med Genet 143:373-380.
20. Carlesimo GA, Marotta L, Vicari S (1997). Long-term memory in mental retardation: evidence for a specific impairment in subjects with Down's syndrome. Neuropsychologia 35:71-79.
21. Carr EG, Horner RH, Turnbull AP, Marquis J, Magito-McLaughlin D, McAtee ML, et al. (1999). Positive behavior support for people with developmental disabilities: a research synthesis. In: American Association on Mental Retardation, editors. Monograph of the American Association on Mental Retardation. Washington, DC: American Association on Mental Retardation. pp. 3-18.
22. Carr EG, Dunlap G, Horner RH, Koegel RL, Turnbull AP, Sailor W, et al. (2002). Positive behavior support: evolution of an applied science. J Positive Behav Intervent 4:4-16.
23. Carr J (2012). Six weeks to 45 years: a longitudinal study of a population with Down syndrome. J Appl Res Intellect Disabil 25:414-422.
24. Carter JC, Capone GT, Gray RM, Cox CS, Kaufmann WE (2007). Autistic spectrum disorders in Down syndrome: further delineation and distinction from other behavioral abnormalities. Am J Med Genet B Neuropsychiatr Genet 144:87-94.
25. Caselli MC, Vicari S, Longobardi E, Lami L, Pizzoli C, Stella G (1998). Gestures and words in early development of children with Down syndrome. J Speech Lang Hear Res 41:1125-1135.
26. Chapman RS (1995). Language development in children and adolescents with Down syndrome. In: Fletcher P, MacWinney B, editors. The handbook of child language. Oxford: Blackwell. pp. 641-663.
27. Clark D, Wilson GN (2003). Behavioral assessment of children with Down syndrome using the Reiss psychopathology scale. Am J Med Genet A 118:210-216.
28. Cocchi G, Gualdi S, Bower C, Halliday J, Jonsson B, Myrelid A, et al. (2010). International trends of Down syndrome 1993-2004: births in relation to maternal age and terminations of pregnancies. Birth Defects Res A Clin Mol Teratol 88:474-479.
29. Coe D, Matson J, Russell D, Slifer K, Capone G, Baglio C, Stallings S (1999). Behavior problems of children with Down syndrome and life events. J Autism Dev Disord 29:149-156.
30. Collacott RA, Cooper SA, McGrother C (1992). Differential rates of psychiatric disorders in adults with Down's syndrome compared with other mentally handicapped adults. Br J Psychiatry 161:671-674.
31. Collip D, Myin-Germeys I, Van Os J (2008). Does the concept of 'sensitization' provide a plausible mechanism for the putative link between the environment and schizophrenia? Schizophr Bull 34:220-225.
32. Conners FA, Rosenquist CJ, Arnett L, Moore MS, Hume LE (2008). Improving memory span in children with Down syndrome. J Intellect Disabil Res 52:244-255.
33. Cooper SA, Collacott RA (1994). Clinical features and diagnostic criteria of depression in Down's syndrome. Br J Psychiatry 165:399-403.
34. Cooper SA, Melville CA, Einfeld SL (2003). Psychiatric diagnosis, intellectual disabilities and Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities/Mental Retardation (DC-LD). J Intellect Disabil Res 47:3-15.
35. Cromer R (1987). The cognition hypothesis revisited. In: Kessel F, editor. The development of language and language researches. Hillsdale, NJ: Erlbaum. pp. 48-65.
36. Des Noyers Hurley A (1996). Psychiatric disorders in children and adolescents with mental retardation and developmental disabilities. Curr Opn Pediatr 8:361-365.
37. Di Nuovo S, Buono S (2011). Behavioral phenotypes of genetic syndromes with intellectual disability: comparison of adaptive profiles. Psychiatry Res 89:440-445.
38. Dodd P, Dowling S, Hollins S (2005). A review of the emotional, psychiatric and behavioural responses to bereavement in people with intellectual disabilities. J Intellect Disabil Res 49:537-543.
39. Dykens EM (2000). Psychopathology in children with intellectual disability. J Child Psychol Psychiatry 41:407-417.
40. Dykens EM (2007). Psychiatric and behavioral disorders in persons with Down syndrome. Ment Retard Dev Disabil Res Rev 13:272-278.
41. Dykens EM, Kasari C (1997). Maladaptive behavior in children with Prader-Willi syndrome, Down syndrome, and non-specific mental retardation. Am J Ment Retard 102:228-237.
42. Dykens EM, Shah B, Sagun J, Beck T, King BH (2002). Maladaptive behavior in children and adolescents with Down's syndrome. J Intellect Disabil Res 46:484-492.
43. Edgin JO, Mason GM, Allman MJ, Capone GT, DeLeon I, Maslen C, et al. (2010). Development and validation of the Arizona Cognitive Test Battery for Down syndrome. J Neurodev Disord 2:149-164.
44. Einfeld S, Tonge B, Chapman L, Taffe J, Horstead S, Pumphrey R, et al. (2007). Inter-rater reliability of the diagnoses of psychosis and depression in individuals with intellectual disabilities. J Appl Res Intellect Disabil 20:384-390.
45. Einfeld SL (1992). Clinical assessment of psychiatric symptoms in mentally retarded individuals. Aust N Z J Psychiatry 26:149-63.
46. Einfeld SL, Tonge BJ (1996). Population prevalence of psychopathology in children and adolescents with intellectual disabilities. II. Epidemiological findings. J Intellect Disabil Res 40:99-109.
47. Ellis JM, Tan HK, Gilbert RE, Muller DP, Henley W, Moy R (2008). Supplementation with antioxidants and folinic acid for children with Down's syndrome: randomized controlled trial. BMJ 336:594-597.
48. Engel C, Szrama E, Habler F (2010). Psychopharmacological therapy in mental retardation. Comparison of the years 1991 and 2005. Psychiatr Prax 37:391-396.
49. Eisermann MM, DeLaRaillere A, Dellatolas G, Tozzi E, Nabbout R, Dulac O, et al. (2003). Infantile spasms in Down syndrome. Effects of delayed anticonvulsive treatment. Epilepsy Res 55:21-27.
50. Epstein CJ (1989). Down syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle P, editors. The metabolic basis of inherited disease. New York: McGraw-Hill. pp. 291-396.
51. Evenhuis HM, Kengen MF, Eurlings AL (2006). Dementia Questionnaire for People with Intellectual Disabilities (DLD). Sydney: Pearson Psychocorp.
52. Fabbretti D, Pizzuto E, Vicari S, Volterra V (1997). A story description task in children with Down syndrome: lexical and morphosyntactic abilities. J Intellect Disabil Res 41:165-179.
53. Fallone G, Owens JA, Deane J (2002). Sleepiness in children and adolescents: clinical implications. Sleep Med Rev 6:287-306.
54. Feeley K, Jones E (2006). Addressing challenging behaviour in children with Down syndrome: the use of applied behaviour analysis for assessment and intervention. Downs Syndr Res Pract 11:64-77.
55. Feeley K, Jones E (2008). Strategies to address challenging behaviour in young children with Down syndrome. Downs Syndr Res Pract 12:153-163.
56. Fernandez F, Morishita W, Zuniga E, Nguyen J, Blank M, Malenka RC, Garner CC (2007). Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat Neurosci 10:411-413.
57. Fletcher R, Loschen E, Stavrakaki C, First M (2007). Diagnostic Manual- Intellectual Disability (DM-ID): a textbook of diagnosis of mental disorders in persons with intellectual disability. Kingston, NY: NADD Press.
58. Fletcher R, Havercamp SM, Ruedrich SL, Benson BA, Barnhill LJ, Cooper SA, et al. (2009). Clinical usefulness of the diagnostic manual-intellectual disability for mental disorders in persons with intellectual disability: results from a brief field survey. J Clin Psychiatry 70:967-974.
59. Fowler AE (1990). Language abilities in children with Down syndrome: evidence for a specific delay. In: Cicchetti D, Beeghley M, editors. Children with Down syndrome: a developmental perspective. Cambridge, MA: Cambridge University Press. pp. 302-328.
60. Franco F, Wishart F (1995). The use of pointing and other gestures by young children with children with Down syndrome. Am J Ment Retard 100: 160-182.
61. Frenkel S, Bourdin B (2009). Verbal, visual, and spatio-sequential short-term memory: assessment of the storage capacities of children and teenagers with Down's syndrome. J Intellect Disabil Res 53:152-160.
62. Gath A, Gumley D (1986). Behaviour problems in retarded children with special reference to Down's syndrome. Br J Psychiatry 149:156-161.
63. Gedye A (1992). Compulsive behavior checklist for clients with mental retardation. Habilitat Ment Health 11:73-77.
64. Gedye A (1996). Issues involved in recognizing obsessive-compulsive disorder in developmentally disabled clients. Semin Clin Neuropsychiatry 1:142-147.
65. Gedye A (1998). Behavioural diagnostic guide for developmental disabilities. Vancouver: Diagnostic Books. Ghaziuddin M (2000). Autism in Down's syndrome: a family history study. J Intellect Disabil Res 44:562-566.
66. Gibson D (1978). Down syndrome: the psychology of mongolism. London: Cambridge University Press.
67. Goday-Arno A, Cerda-Esteva M, Flores-Le-Roux JA, Corretger JM, Chillaron- Jordan JJ, Cano-Pé erez JF (2009). Hyperthyroidism in a population with Down syndrome. Clin Endocrinol (Oxf) 71:110-114.
68. Goldberg-Stern H, Strawsburg RH, Patterson B, Hickey F, Bare M, Gadoth N, Degrauw TJ (2001). Seizure frequency and characteristics in children with Down syndrome. Brain Dev 23:275-278.
69. Green JM, Dennis J, Bennets LA (1989). Attention disorder in a group of young Down's syndrome children. J Ment Defic Res 33:105-122.
70. Handen B, Gilchrist R (2006). Psychopharmacology in children and adolescents with mental retardation. J Child Psychol Psychiatry 47:871-882.
71. Holden B, Gitlesen JP (2004). Psychotropic medication in adults with mental retardation: prevalence, and prescription practices. Res Dev Disabil 25: 509-521.
72. Howlin P, Wing L, Gould J (1995). The recognition of autism in children with Down syndrome. Implications for intervention and some speculations about pathology. Dev Med Child Neurol 37:398-414.
73. Huxley A, Prashner VP, Hague MS (2000). The Dementia Scale for Down's Syndrome. J Intellect Disabil Res 44:697-698.
74. Iverson J, Longobardi E, Caselli MC (2003). The relationship between gestures and words in children with Down syndrome and typically-developing children in the early stages of communicative development. Int J Lang Commun Disord 38:179-197.
75. Janicki MP, Dalton AJ (2000). Prevalence of dementia and impact on intellectual disability services. Ment Retard 38:276-288.
76. Jarrold C, Baddeley AD (1997). Short-term memory for verbal and visuo-spatial information in Down's syndrome. Cogn Neuropsychiatry 1:101-122.
77. Jarrold C, Baddeley AD, Hewes AK (1999). Genetically dissociated components of working memory: evidence from Down and Williams syndrome. Neuropsychologia 37:637-651.
78. Kent L, Evans J, Paul M, Sharp M (1999). Comorbidity of autistic spectrum disorders in children with Down syndrome. Dev Med Child Neurol 41:153-158.
79. Kesslak JP, Nagata SF, Lott I, Nalcioglu O (1994). Magnetic resonance imaging analysis of age-related changes in the brains of individuals with Down syndrome. Neurology 44:1039-1045.
80. Klein BP, Mervis CB (1999). Cognitive strength and weaknesses of 9- and 10- year-olds with Williams syndrome or Down syndrome. Dev Neuropsychol 16:177-196.
81. Klosterkotter J, Ebel H, Schultze-Lutter F, Steinmeyer EM (1996). Diagnostic validity of basic symptoms. Eur Arch Psychiatry Clin Neurosci 246:147-154.
82. Landt J, D'Abrera JC, Holland AJ, Aigbirhio FI, Fryer TD, Canales R, et al. (2011). Using positron emission tomography and Carbon 11-labeled Pittsburgh compound B to image brain fibrillar b-amyloid in adults with Down syndrome: safety, acceptability, and feasibility. Arch Neurol 68:890-896.
83. Lanfranchi S, Cornoldi C, Vianello R (2004). Verbal and visuospatial working memory deficits in children with Down syndrome. Am J Ment Retardation 109:456-466.
84. Lejeune J (1990). Pathogenesis of mental deficiency in trisomy 21. Am J Med Genet 7:20-30.
85. Lemons CJ, Fuchs D (2010). Phonological awareness of children with Down syndrome: its role in learning to read and the effectiveness of related interventions. Res Dev Disability 31:316-330.
86. Levanon A, Tarasiuk A, Tal A (1999). Sleep characteristics in children with Down syndrome. J Pediatr 134:755-760.
87. Lockrow JP, Fortress AM, Granholm AC (2012). Age-related neurodegeneration and memory loss in Down syndrome. Curr Gerontol Geriatr Res 2012 doi:10.1155/2012/463909.
88. Lott IT, Dierssen M (2010). Cognitive deficits and associated neurological complications in individuals with Down's syndrome. Lancet Neurol 9: 623-633.
89. Lott IT, Head E, Doran E, Busciglio J (2006). Beta-amyloid, oxidative stress and Down syndrome. Curr Alzheimer Res 3:521-528.
90. Luciana M, Nelson CA (2002). Assessment of neuropsychological function in children through the Cambridge Neuropsychological Testing Automated Battery (CANTAB): normative performance in 4 to 12 year-olds. Dev Neuropsychol 22:595-624.
91. Maatta T, Tervo-Maatta T, Taanila A, Kaski M, Ilvanalnen M (2006). Mental health, behaviour and intellectual ability in people with Down syndrome. Downs Syndr Res Pract 11:37-43.
92. Mahoney G, Perales F,Wiggers B, Herman B (2006). Responsive teaching: early intervention for children with Down syndrome and other disabilities. Down Syndr Res Pract 11:18-28.
93. Mantry D, Cooper SA, Smiley E, Morrison J, Allan L, Jackson A (2008). The prevalence and incidence of mental ill-health in adults with Down syndrome. J Intellect Disabil Res 52:141-155.
94. Matson JL (1995). The diagnostic assessment for the severely handicapped revised (DASH-II). Baton Rouge, LA: Disability Consultants, LLC.
95. Matson JL, Smiroldo BB (1997). Validity of the mania subscale of the diagnostic assessment for the severely handicapped-II (DASH-II). Res Dev Disabil 18:221-225.
96. Mazzone L, Ruta L, Reale L (2012). Psychiatric comorbidities in asperger syndrome and high functioning autism: diagnostic challenges. Ann Gen Psychiatry 25:11-16.
97. McCarthy J (2008). Behaviour problems and adults with Down syndrome: childhood risk factors. J Intellect Disabil Res 52:877-882.
98. McCarthy J, Boyd J (2001). Psychopathology and young people with Down's syndrome: childhood predictors and adult outcome of disorder. J Intellect Disabil Res 45:99-105.
99. Means MK, Lichstein KL, Edinger JD, Taylor DJ, Durrence HH, Husain AM, et al. (2003). Changes in depressive symptoms after continuous positive airway pressure treatment for sleep apnea. Sleep Breath 7:31-42.
100. Menghini D, Costanzo F, Vicari S (2011). Relationship between brain and cognitive processes in Down syndrome. Behav Genet 41:381-393.
101. Mervis CB, Robinson BR (2000). Expressive vocabulary ability of toddlers with Williams syndrome or Down syndrome: a comparison. Dev Neuropsychol 17:111-126.
102. Miller JF (1992). Development of speech and language in children with Down syndrome. In: Lott IT, Mc Loy EE, editors. Down syndrome. New York: Wiley- Liss. pp. 39-50.
103. Mohan M, Bennet C, Carpenter PK (2009a). Galantamine for dementia in people with Down syndrome. Cochrane Database Syst Rev 21:CD007656.
104. Mohan M, Bennet C, Carpenter PK (2009b). Memantine for dementia in people with Down syndrome. Cochrane Database Syst Rev 21:CD007657.
105. Mohan M, Carpenter PK, Bennet C (2009c). Donepezil for dementia in people with Down syndrome. Cochrane Database Syst Rev 21:CD007658.
106. Morgan VA, Leonard H, Bourke J, Jablensky A (2008). Intellectual disability cooccurring with schizophrenia and other psychiatric illness: populationbased study. Br J Psychiatry 193:364-372.
107. Moss MB, Albert MS, Butters N, Payne M (1986). Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease, and alcoholic Korsakoff's syndrome. Arch Neurol 43:239-246.
108. Myers BA, Pueschel SM (1991). Psychiatric disorders in persons with Down syndrome. J Nerv Ment Dis 179:609-613.
109. Myers BA, Pueschel SM (1995). Major depression in a small group of adults with Down syndrome. Res Dev Disabil 16:285-299.
110. Næss KA, Melby-Lervag M, Hulme C, Lyster SA (2012). Reading skills in children with Down syndrome: a meta-analytic review. Res Dev Disabil 33:737-747.
111. National Institute for Health and Clinical Excellence (NICE) (2006). National Institute for Health and Clinical Excellence published clinical guidelines for dementia. London, UK: NICE.
112. Nicham R,Weitzdorfer R, Hauser E, Freidl M, Schubert M,Wurst E, et al. (2003). Spectrum of cognitive, behavioural and emotional problems in children and young adults with Down syndrome. J Neural Transm Suppl 67: 173-191.
113. Oliver C, Crayton L, Holland A, Hall S, Bradbury J (1998). A four year prospective study of age-related cognitive change in adults with Down's syndrome. Psychol Med 28:1365-1377.
114. Pary RJ, Hurley AD (2002). Down syndrome and autistic disorder. Mental Health Asp Dev Disabil 5:64-65.
115. Patel V, Flisher AJ, Hetrick S, McGorry P (2007). Mental health of young people: a global public-health challenge. Lancet 369:1302-1313.
116. Pennington BF, Moon J, Edgin J, Stedron J, Nadel L (2003). The neuropsychology of Down syndrome: evidence for hippocampal dysfunction. Child Dev 74: 75-93.
117. Prasher VP (1995). Prevalence of psychiatric disorders in adults with Down syndrome. Eur J Psychiatry 9:77-82.
118. Prasher VP, Farooq A, Holder R (2004). The Adaptive Behaviour Dementia Questionnaire (ABDQ): screening questionnaire for dementia in Alzheimer's disease in adults with Down syndrome. Res Dev Disabil 25:385-397.
119. Prasher VP, Fung N, Adams C (2005). Rivastigmine in the treatment of dementia in Alzheimer's disease in adults with Down syndrome. Int J Geriatr Psychiatry 20:496-497.
120. Pueschel SM, Bernier JC, Pezullo JC (1991). Behavioral observations of children with Down syndrome. J Ment Defic Res 35:502-511.
121. Rasmussen P, Borjesson O, Wentz E, Gillberg C (2001). Autistic disorders in Down syndrome: background factors and clinical correlates. Dev Med Child Neurol 43:750-754.
122. Raz N, Torres IJ, Briggs SD, Spencer WD, Thornton AE, Loken WJ (1995). Selective neuroanatomic abnormalities in Down syndrome and their cognitive correlates: evidence from MRI morphometry. Neurology 45:356-366.
123. Reichle J,Wacker D (1993). Communicative alternatives to challenging behavior: integrating functional assessment and intervention strategies. Baltimore: Paul H. Brookes.
124. Reiss S (1990). Prevalence of dual diagnosis in community based day programs in the Chicago metropolitan area. Am J Ment Def 94:578-588.
125. Reiss S, Levitan GW, Szyszko J (1982). Emotional disturbance and mental retardation: diagnostic overshadowing. Am J Ment Def 86:567-574.
126. Resta O, Barbaro M, Giliberti T, Caratozzolo G, Cagnazzo M, Scarpelli F, et al. (2003). Sleep related breathing disorders in adults with Down syndrome. Downs Syndr Res Pract 8:115-119.
127. Rondal JA, Ghiotto M, Bré dart S, Bachelet JF (1988). Mean length of utterance of children with Down syndrome. Am J Ment Retard 3:64-66.
128. Rondal JA (1993). Exceptional cases of language development in mental retardation: the relative autonomy of language as a cognitive system. In: Tager-Flusberg, editor. Constraints on language acquisition: studies of atypical children. Hillsdale, NJ: Erlbaum. pp. 155-174.
129. Roper RJ, Reeves RH (2006). Understanding the basis for Down syndrome phenotypes. PLoS Genet 2:e50.
130. Royal College of Psychiatrists (2001). DC-LD (Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities/Mental Retardation). London: Gaskell Press.
131. Sekijima Y, Ykeda SI, Tokuda T, Satoh SI, Hidaka H, Hidaka E, et al. (1998). Prevalence of dementia of Alzheimer type and apolipoprotein E phenotypes in aged patients with Down's syndrome. Eur Neurol 39:234-237.
132. Singer Harris NG, Bellugi U, Bates E, Jones W, Rossen M (1997). Contrasting profiles of language in children with Williams and Down syndromes. Dev Neuropsychol 13:345-370.
133. Sovner R, Hurley A, Labrie R (1985). Is mania incompatible with Down's syndrome? Br J Psychiatry 146:319-320.
134. Snider L, Swedo S (2004). PANDAS: current status and research directions. Mol Psychiatry 9:900-907.
135. Stanton LR, Coetzee RH (2004). Down's syndrome and dementia. Adv Psychiatr Treat 10:50-58.
136. Starr EM, Berument SK, Tomlinds M, Papanikolaou K, Rutter M (2005). Brief report: autism in individuals with Down syndrome. J Autism Dev Disord 35:665-673.
137. Stores R, Stores G, Fellows B, Buckley S (1998). Daytime behavior problems and maternal distress in children with Down syndrome, their siblings, and nonintellectually disabled and other intellectually disabled peers. J Intellect Disabil Res 42:228-237.
138. Strick PL, Dum RP, Fiez JA (2009). Cerebellum and non motor function. Annu Rev Neurosci 32:413-434.
139. Szymanski L, King BH (1999). Summary of the practice parameters for the assessment and treatment of children, adolescents, and adults with mental retardation and comorbid mental disorders. J Am Acad Child Adolesc Psychiatry 38:1606-1610.
140. Tanzi RE, Gusella J, Watkins P, Bruns G, George-Hyslop PS, Van Keuren ML, et al. (1987). Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235:880-884.
141. Ulzen TP, Powers E (2008). A Review of empirical evidence of somatic treatment options for the MI/DD population. Psychiatr Q 79:265-273.
142. Vicari S (2006). Motor development and neuropsychological patterns in persons with Down syndrome. Behav Genet 36:355-364.
143. Vicari S, Caselli MC, Tonucci F (2000). Early language development in Italian children with Down syndrome: asynchrony of lexical and morphosyntactic abilities. Neuropsychologia 38:634-644.
144. Vicari S, Bellucci S, Carlesimo GA (2001). Procedural learning deficit in children with Williams syndrome. Neuropsychologia 39:665-677.
145. Vicari S, Carlesimo GA (2002). Children with intellectual disabilities. In: Baddeley A,Wilson B, Kopelman M, editors. Handbook of memory disorders. West Sussex, UK: John Wiley & Sons Ltd. pp. 501-518.
146. Vicari S, Marotta L, Carlesimo GA (2004). Verbal short-term memory in Down's syndrome: an articulatory loop deficit? J Intellect Disabil Res 48:80-92.
147. Vicari S, Bellucci S, Carlesimo GA (2005). Visual and spatial long-term memory: differential pattern of impairments in Williams and Down syndromes. Dev Med Child Neurol 47:305-311.
148. Vicari S, Bellucci S, Carlesimo GA (2006). Evidence from two genetic syndromes for the independence of spatial and visual working memory. Dev Med Child Neurol 48:126-131.
149. Vicari S, Verucci L, Carlesimo GA (2007). Implicit memory is independent from IQ and age but not from etiology: evidence from Down and Williams syndrome. J Intellect Disabil Res 51:932-941.
150. Wang PP, Bellugi U (1994). Evidence from two genetic syndromes for dissociation between verbal and visual-spatial short-term memory. J Clin Exp Neuropsychol 16:317-322.
151. Wishart JG (2007). Socio-cognitive understanding: a strength or weakness in Down syndrome? J Intellect Disabil Res 51:996-1005.
152. Wisniewski KE, Wisniewski HM, Wen GY (1985). Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 17:278-282.
153. Wisniewski KE (1990). Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dygenesis. Am J Med Genet Suppl 7:274-281.
154. Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane CA, Hallgren M (2003). Psychosis prediction: 12-month follow up of a high-risk (prodromal) group. Schizophr Res 60:21-32.
155. Visu-Petra L, Benga O, Tincaş I, Miclea M (2007). Visual-spatial processing in children and adolescents with Down's syndrome: a computerized assessment of memory skills. J Intellect Disabil Res 51:942-952.
156. Vitiello B, Spreat S, Behar D (1989). Obsessive-compulsive disorder in mentally retarded patients. J Nerv Ment Dis 177:232-236.
157. White NS, Alkire MT, Haier RJ (2003). A voxel-based morphometric study of nondemented adults with Down Syndrome. NeuroImage 20: 393-403.